.png)
fatigue and tirzepatide - What to Know Does Tirzepatide Make You Tired?
Description
Tirzepatide is administered subcutaneous once weekly with a recommended dose-escalation regimen, initiated by 2.5 mg for 4 weeks and increased by 2.5 mg every 4 weeks until reaching a maintenance dose between 5 and 15 mg (Gasbjerg et al., 2023)
Su-yuan, C., Xiao-jing, L., & Jian-hui, L
Understanding long-term outcomes, maintenance strategies, and insights from clinical studies can help patients plan for lasting weight control
Most people researching retatrutide online see the 12 mg number from the phase 3 trial and assume that is the target
Toxicon 62 , 1926 (2013)
